Baraldo M - Search Results

1

Comparison of clinical effects, trough and peak levels between branded and generic formulation of Cyclosporine in stable psoriatic patients.

Buligan C, Pinzani C, Cimarosti R, Stinco G, Baraldo M. Buligan C, et al. Among authors: baraldo m. G Ital Dermatol Venereol. 2020 Aug;155(4):452-458. doi: 10.23736/S0392-0488.18.05860-1. Epub 2018 Mar 26. G Ital Dermatol Venereol. 2020. PMID: 29582618

2

Oral and intravenous disposition of cyclosporine in psoriatic patients.

Galla F, Marzocchi V, Croattino L, Poz D, Baraldo M, Furlanut M. Galla F, et al. Among authors: baraldo m. Ther Drug Monit. 1995 Jun;17(3):302-4. Ther Drug Monit. 1995. PMID: 7624927

3

Blood concentrations and clinical effect of cyclosporin in psoriasis.

Furlanut M, Baraldo M, Pea F, Marzocchi V, Croattino L, Galla F. Furlanut M, et al. Among authors: baraldo m. Ther Drug Monit. 1996 Oct;18(5):544-8. doi: 10.1097/00007691-199610000-00004. Ther Drug Monit. 1996. PMID: 8885117 Clinical Trial.

4

Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients.

Baraldo M, Pea F, Poz D, Furlanut M. Baraldo M, et al. Pharmacol Res. 2001 Jun;43(6):547-51. doi: 10.1006/phrs.2001.0823. Pharmacol Res. 2001. PMID: 11419964

5

Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.

Baraldo M, Ferraccioli G, Pea F, Gremese E, Furlanut M. Baraldo M, et al. Pharmacol Res. 1999 Dec;40(6):483-6. doi: 10.1006/phrs.1999.0539. Pharmacol Res. 1999. PMID: 10660945

6

Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients.

Baraldo M, Pea F, Poz D, Albanese MC, Livi U, Furlanut M. Baraldo M, et al. Transplant Proc. 2001 Nov-Dec;33(7-8):3151-3. doi: 10.1016/s0041-1345(01)02342-9. Transplant Proc. 2001. PMID: 11750353 No abstract available.

7

C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses.

Baraldo M, Francesconi A, Barbone F, Tursi V, Livi U, Furlanut M. Baraldo M, et al. Transplant Proc. 2002 Dec;34(8):3246-8. doi: 10.1016/s0041-1345(02)03699-0. Transplant Proc. 2002. PMID: 12493435 No abstract available.

8

Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation.

Baraldo M, Risaliti A, Bresadola F, Chiarandini P, Dalla Rocca G, Furlanut M. Baraldo M, et al. Transplant Proc. 2003 Jun;35(4):1449-51. doi: 10.1016/s0041-1345(03)00517-7. Transplant Proc. 2003. PMID: 12826188

9

Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.

Baraldo M, Cojutti PG, Isola M, Feruglio MT, Tursi V, Livi U, Furlanut M. Baraldo M, et al. Transplant Proc. 2009 Dec;41(10):4277-84. doi: 10.1016/j.transproceed.2009.08.077. Transplant Proc. 2009. PMID: 20005384

10

Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.

Franceschi L, Cojutti P, Baraldo M, Pea F. Franceschi L, et al. Among authors: baraldo m. Ther Drug Monit. 2014 Oct;36(5):674-6. doi: 10.1097/FTD.0000000000000054. Ther Drug Monit. 2014. PMID: 24637698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters